Overview
Premenstrual dysphoric disorder is a cyclical disorder presenting with distressing mood and behavioral symptoms that occur during the late luteal phase of the ovulatory cycle; it is a severe form of premenstrual syndrome.
It results in considerable impairment of the patient's personal functioning that occurs in approximately 5% of women of reproductive age.
The goals of therapy are to reduce symptoms and improve social and occupational performance needed for improved quality of life.
Selective Serotonin Reuptake Inhibitors (SSRIs) is considered the first-line treatment for severe premenstrual dysphoric disorder. While hormonal intervention therapy is considered if treatment with other methods was unsuccessful.
For further information regarding the management of Premenstrual Dysphoric Disorder, please refer to Disease Algorithm for the Treatment Guideline.
It results in considerable impairment of the patient's personal functioning that occurs in approximately 5% of women of reproductive age.
The goals of therapy are to reduce symptoms and improve social and occupational performance needed for improved quality of life.
Selective Serotonin Reuptake Inhibitors (SSRIs) is considered the first-line treatment for severe premenstrual dysphoric disorder. While hormonal intervention therapy is considered if treatment with other methods was unsuccessful.
For further information regarding the management of Premenstrual Dysphoric Disorder, please refer to Disease Algorithm for the Treatment Guideline.